Spexis AG (STU:29Y) Total Stockholders Equity : €2.43 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Spexis AG Total Stockholders Equity?

Spexis AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €2.43 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Spexis AG's Book Value per Share for the quarter that ended in Dec. 2023 was €0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Spexis AG's Debt-to-Equity for the quarter that ended in Dec. 2023 was 3.64.

Spexis AG Total Stockholders Equity Historical Data

The historical data trend for Spexis AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG Total Stockholders Equity Chart

Spexis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

50.48

-10.43

28.94

19.66

2.43

Spexis AG Semi-Annual Data
	Dec13	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial													28.94	25.95	19.66	17.71	2.43

Spexis AG (STU:29Y) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Spexis AG's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2.426	-	0)	/	58.9645
	=	0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Spexis AG's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.706	+	6.125)	/	2.426
	=	3.64

Spexis AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Spexis AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Spexis AG (STU:29Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (STU:29Y) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SPEXz:UK SPEX:Switzerland

Address

Hegenheimermattweg 125, Allschwil, CHE, CH-4123

Website

https://www.polyphor.com

Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (STU:29Y) Headlines

No Headlines